In this slide contains Introduction, levels of cleaning, mechanism, sampling method of cleaning validation.
Presented by: P. VENKATESH (Department of pharmaceutical analysis).RIPER, anantapur
The document discusses pharmaceutical validation including definitions of qualification and validation. It provides details on types of qualification including design, installation, operational and performance qualification. Validation types such as prospective, concurrent and retrospective validation are summarized. The importance of validation master plan and validation protocols are highlighted. Key aspects of streamlining validation operations are also covered such as the importance of parallel development of API, analytical methods and drug product.
University Institute of Pharmaceutical Sciences is a flag bearer of excellence in Pharmaceutical education and research in the country. Here is another initiative to make study material available to everyone worldwide. Based on the new PCI guidelines and syllabus here we have a presentation dealing with qualifications of HPLC which is the " High Performance Liquid Chromatography".
Thank you for reading.
Hope it was of help to you.
UIPS,PU team
This document provides standard operating procedures for qualifying various laboratory equipment used in pharmaceutical quality control testing. It includes procedures for calibrating hardness testers, friability test apparatus, tap density testers, disintegration testers, and dissolution test apparatus. The qualification process involves design qualification, installation qualification, operational qualification, and performance qualification to ensure equipment is properly installed, works correctly, and provides expected results. Calibration procedures are also described to verify equipment meets specifications.
The document discusses the qualification of an FTIR analytical instrument. It describes various parameters used to ensure instrument quality such as validation, calibration, and maintenance. Qualification involves collecting evidence that the instrument is suitable for its intended purpose and includes design qualification, installation qualification, operational qualification, and performance qualification phases. The document then discusses specific tests and acceptance criteria for qualifying an FTIR, including tests for resolution, wave number accuracy and reproducibility, transmittance reproducibility, and other tests to evaluate the instrument over time according to ASTM standards.
Analytical method validation as per ich and usp shreyas B R
Analytical method validation is a process of documenting/ proving that an analytical method provides analytical data acceptable for the intended use.After the development of an analytical procedure, it is must important to assure that the procedure will consistently produce the intended a precise result with high degree of accuracy. The method should give a specific result that may not be affected by external matters. This creates a requirement to validate the analytical procedures. The validation procedures consists of some characteristics parameters that makes the method acceptable with addition of statistical tools.
Qualification of analytical instrumentsFaris ameen
This document provides guidelines for qualifying analytical instruments including electronic balances, pH meters, and UV-Visible spectrophotometers. It discusses the various levels of qualification including: Level I which involves selecting instruments and suppliers; Level II which involves installation and releasing instruments for use; Level III which involves periodic checks; and Level IV which involves in-use checks. Specific guidelines are provided for qualifying balances, pH meters, and UV-Visible spectrophotometers, including recommended tolerance limits for various parameters, calibration procedures, and qualification frequencies.
In this slide contains Introduction, levels of cleaning, mechanism, sampling method of cleaning validation.
Presented by: P. VENKATESH (Department of pharmaceutical analysis).RIPER, anantapur
The document discusses pharmaceutical validation including definitions of qualification and validation. It provides details on types of qualification including design, installation, operational and performance qualification. Validation types such as prospective, concurrent and retrospective validation are summarized. The importance of validation master plan and validation protocols are highlighted. Key aspects of streamlining validation operations are also covered such as the importance of parallel development of API, analytical methods and drug product.
University Institute of Pharmaceutical Sciences is a flag bearer of excellence in Pharmaceutical education and research in the country. Here is another initiative to make study material available to everyone worldwide. Based on the new PCI guidelines and syllabus here we have a presentation dealing with qualifications of HPLC which is the " High Performance Liquid Chromatography".
Thank you for reading.
Hope it was of help to you.
UIPS,PU team
This document provides standard operating procedures for qualifying various laboratory equipment used in pharmaceutical quality control testing. It includes procedures for calibrating hardness testers, friability test apparatus, tap density testers, disintegration testers, and dissolution test apparatus. The qualification process involves design qualification, installation qualification, operational qualification, and performance qualification to ensure equipment is properly installed, works correctly, and provides expected results. Calibration procedures are also described to verify equipment meets specifications.
The document discusses the qualification of an FTIR analytical instrument. It describes various parameters used to ensure instrument quality such as validation, calibration, and maintenance. Qualification involves collecting evidence that the instrument is suitable for its intended purpose and includes design qualification, installation qualification, operational qualification, and performance qualification phases. The document then discusses specific tests and acceptance criteria for qualifying an FTIR, including tests for resolution, wave number accuracy and reproducibility, transmittance reproducibility, and other tests to evaluate the instrument over time according to ASTM standards.
Analytical method validation as per ich and usp shreyas B R
Analytical method validation is a process of documenting/ proving that an analytical method provides analytical data acceptable for the intended use.After the development of an analytical procedure, it is must important to assure that the procedure will consistently produce the intended a precise result with high degree of accuracy. The method should give a specific result that may not be affected by external matters. This creates a requirement to validate the analytical procedures. The validation procedures consists of some characteristics parameters that makes the method acceptable with addition of statistical tools.
Qualification of analytical instrumentsFaris ameen
This document provides guidelines for qualifying analytical instruments including electronic balances, pH meters, and UV-Visible spectrophotometers. It discusses the various levels of qualification including: Level I which involves selecting instruments and suppliers; Level II which involves installation and releasing instruments for use; Level III which involves periodic checks; and Level IV which involves in-use checks. Specific guidelines are provided for qualifying balances, pH meters, and UV-Visible spectrophotometers, including recommended tolerance limits for various parameters, calibration procedures, and qualification frequencies.
The document discusses the qualification of high performance thin layer chromatography (HPTLC). It describes the four types of qualification: design qualification, installation qualification, operation qualification, and performance qualification. Design qualification verifies specifications and review methods. Installation qualification documents compliance at installation. Operation qualification documents consistent performance within operating ranges. Performance qualification ascertains the instrument is suitable for specific analytical tasks. The document then provides examples of tests to check HPTLC performance, including linearity of spotting, reproducibility of spotting, and detection capacity.
This presentation explains about qualifications of HPTLC, types of qualifications, design qualification , installation qualification ,operational qualification, performance qualification ,documentation of qualification .
cGMP Guidelines According to Schedule MANKUSH JADHAV
This document provides an overview of cGMP guidelines according to Schedule M. It defines cGMP and outlines key areas that must be addressed including personnel, premises, equipment, standard operating procedures, raw materials, self inspections, master formula records, batch manufacturing records, warehousing, and validation. The guidelines ensure quality products are consistently produced and that quality is built into every step of the manufacturing process.
ANALYSIS OF RAW MATERIALS, FINISHED PRODUCTS, PACKAGING MATERIALS, IPQC, CPCS...Khadeeja6
RAW MATERIALS
It is basically the chemical ingredients of a process. starting material, in production of final product.
FINISHED PRODUCTS
Marketable product, transportable pack, salable pack
PACKAGING MATERIAL
Providing presentation, protection, identification, information, containment, convenience compliance, integrity and stability for a product during storage, transportation display and until it is consumed or throughout its shelf life.
IPQC
Providing accurate, specific and definite description of the procedures to be employed from the receipt of raw materials to the release of the finished dosage form.
CPCSEA GUIDELINES
Role of CPCSEA is to monitor animal experiments through ethics committees set up in institutions (IAEC)
CPCSEA Nominee -important link between CPCSEA and IAEC
IAEC scrutinize all project proposals for experimentation on animals.
The validity of IAEC is for 3 years.
This document provides qualification procedures for an electronic balance, pH meter, and UV-visible spectrophotometer. It describes design qualification, installation qualification, and operational qualification tests. For the electronic balance, design qualification includes supplier certification. Installation qualification includes installation and operational tests using reference weights. Operational qualification includes daily measurement of reference weights. For the pH meter and spectrophotometer, design qualification includes selection criteria. Installation qualification includes installation and checks. Operational qualification includes calibration and performance verification tests using standards traceable to national references.
QA and QC are related but distinct concepts in quality management. QA refers to the overall system that aims to prevent defects through processes, while QC tests products to identify defects. QA is a preventative system involving all employees to ensure quality standards are met throughout development. In contrast, QC is reactive and conducted by a specialized team to detect defects in finished products before release. Both work together to continually meet customer requirements, with QA focusing on building quality in from the start and QC checking for quality along the way.
Qualification of laboratory equipments by Mayuri SoniMayuri Soni
The document provides standard operating procedures (SOPs) for qualifying common laboratory equipment used for quality control testing of pharmaceuticals. It describes calibration procedures for hardness testers, friability test apparatus, tap density apparatus, disintegration testers, and dissolution test apparatus. The SOPs outline how to test that the equipment meets specifications for factors like force measurements, rotation speeds, temperature control, and oscillations. Regular calibration is necessary to confirm equipment is functioning properly and producing accurate results.
The document discusses the qualification of analytical equipment like electronic balances and pH meters. It explains that qualification includes design, installation, operational and performance qualification to ensure equipment is properly installed and functioning accurately. Specific steps for qualifying balances, such as daily calibration checks with internal weights and yearly checks with external weights, are provided. The two-point calibration method for pH meters using buffer solutions is also described. Acceptance limits and record keeping procedures are outlined to ensure equipment remains calibrated over time.
This guidance provides recommendations for holders of animal drug applications on reporting categories for changes to conditions established in approved applications. It describes changes to manufacturing sites, scales, equipment, specifications, and processes for synthetic drug substances and intermediates. The guidance recommends reporting categories of annual reports, supplements for changes being effected in 30 days, or prior approval supplements based on the type and potential impact of changes.
In this slide contains details about Pharmaceutical validation of water system
Presented by: K VENKATSAI PRASAD (Department of pharmaceutical analysis and quality assurance).RIPER, anantapur
Sanitation in manufacturing premises is essential to prevent contamination of products. It requires keeping all areas clean, including the premises, manufacturing areas, equipment, and personnel. This involves removing dirt, waste, garbage and other sources of infection or disease. Cleaning and sanitation of premises and equipment helps ensure products are not contaminated during the manufacturing, processing, packing or holding of drug products.
This document discusses the qualification of manufacturing equipment. It explains that equipment qualification is necessary to ensure equipment works correctly and produces reliable results. There are four types of qualification: design, installation, operational, and performance. Design qualification defines equipment specifications. Installation qualification confirms proper installation. Operational qualification verifies equipment functions as specified. Performance qualification demonstrates consistent performance under routine use. The document then provides details on specific qualification procedures for dry powder mixers and fluidized bed dryers.
It is process of “Establishing documentary evidence that provide a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes”.
In the pharmaceutical industry, it is very important that in addition to final testing and compliance of products, it is also assured that the process will consistently produce the expected results.
Validation is action of proving in accordance with the principles of good manufacturing practices, that any procedure, process, equipment, material, activity or system actually leads to expected results.
Cleaning validation is documented evidence with a high degree assurance that one can consistently clean a system or a piece of equipment to predetermined and acceptable limits.
The primary regulatory concern driving the need for cleaning validation is cross contamination of the desired drug substance either by other API from previous batch runs or by residues from the cleaning agents used.
The prime purpose of validating a cleaning process is to ensure compliance with federal and other standard regulations
1. Cross contamination with active ingredients
Contamination of one batch of product with significant levels of residual active ingredients from previous batch cannot be tolerated.
In addition to the obvious problems posed by subjecting consumers or patients to unintended contaminants, potential clinically significant synergistic interactions between pharmacologically active chemicals are a real concern.
2. Contamination with unintended materials or compounds
While inert ingredients used in drug products are generally recognized as safe for human consumption, the routine use, maintenance and cleaning of equipment's provide the potential contamination with such items as equipment parts, lubricants and chemical cleaning agents3. Microbiological contamination
Maintenance , cleaning and storage conditions may provide adventitious microorganisms with the opportunity to proliferate within the processing equipment.
The document discusses validation of analytical methods used in cleaning validation. It covers parameters assessed in analytical method validation like specificity, linearity, range, accuracy, precision, LOD, LOQ. It also discusses method validation, cleaning validation, levels of cleaning, cleaning process validation, typical analytical procedures and their applicability. Key aspects of validation covered include equipment and personnel qualification, microbiological considerations, documentation, sampling, rinsing, rinse samples, detergents used and establishment of acceptable limits.
The document discusses validation of critical utility systems used in pharmaceutical manufacturing facilities. It focuses on validation of HVAC, water, and steam systems. For HVAC validation, it provides details on DQ, IQ, OQ, and PQ protocols including objectives, responsibilities, tests performed. It discusses user requirements, specifications for HVAC control and monitoring. For water system validation, it discusses purification methods, grade of water, and protocols for IQ, OQ and PQ. It also discusses two types of steam systems - house steam and clean steam - and validation considerations for each.
In this slide contains introduction, qualification, preventive maintenance, requalification method.
Presented by: Malarvannan M (Department of pharmaceutical analysis).RIPER, anantapur
PIC/S is a combine term used for the execution of activities of Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme
harmonize, educate, and update aspects relating to Good Manufacturing Practice among member countries
harmonized relation among regulatory authorities and governments
members
history
role
objective and function
guidlines
In this slide contains Investigation, reason, case study of OOS.
Presented by: K Venkatsai Preasad. (Department of pharmaceutical analysis and quality assurance).
RIPER, anantapur.
In this slide contains introduction, steps, requirements, principle and quantification methods of HPLC.
Presented by: HIMA BINDHU (Department of pharmaceutical analysis).
RIPER, anantapur
The document discusses the qualification of high performance thin layer chromatography (HPTLC). It describes the four types of qualification: design qualification, installation qualification, operation qualification, and performance qualification. Design qualification verifies specifications and review methods. Installation qualification documents compliance at installation. Operation qualification documents consistent performance within operating ranges. Performance qualification ascertains the instrument is suitable for specific analytical tasks. The document then provides examples of tests to check HPTLC performance, including linearity of spotting, reproducibility of spotting, and detection capacity.
This presentation explains about qualifications of HPTLC, types of qualifications, design qualification , installation qualification ,operational qualification, performance qualification ,documentation of qualification .
cGMP Guidelines According to Schedule MANKUSH JADHAV
This document provides an overview of cGMP guidelines according to Schedule M. It defines cGMP and outlines key areas that must be addressed including personnel, premises, equipment, standard operating procedures, raw materials, self inspections, master formula records, batch manufacturing records, warehousing, and validation. The guidelines ensure quality products are consistently produced and that quality is built into every step of the manufacturing process.
ANALYSIS OF RAW MATERIALS, FINISHED PRODUCTS, PACKAGING MATERIALS, IPQC, CPCS...Khadeeja6
RAW MATERIALS
It is basically the chemical ingredients of a process. starting material, in production of final product.
FINISHED PRODUCTS
Marketable product, transportable pack, salable pack
PACKAGING MATERIAL
Providing presentation, protection, identification, information, containment, convenience compliance, integrity and stability for a product during storage, transportation display and until it is consumed or throughout its shelf life.
IPQC
Providing accurate, specific and definite description of the procedures to be employed from the receipt of raw materials to the release of the finished dosage form.
CPCSEA GUIDELINES
Role of CPCSEA is to monitor animal experiments through ethics committees set up in institutions (IAEC)
CPCSEA Nominee -important link between CPCSEA and IAEC
IAEC scrutinize all project proposals for experimentation on animals.
The validity of IAEC is for 3 years.
This document provides qualification procedures for an electronic balance, pH meter, and UV-visible spectrophotometer. It describes design qualification, installation qualification, and operational qualification tests. For the electronic balance, design qualification includes supplier certification. Installation qualification includes installation and operational tests using reference weights. Operational qualification includes daily measurement of reference weights. For the pH meter and spectrophotometer, design qualification includes selection criteria. Installation qualification includes installation and checks. Operational qualification includes calibration and performance verification tests using standards traceable to national references.
QA and QC are related but distinct concepts in quality management. QA refers to the overall system that aims to prevent defects through processes, while QC tests products to identify defects. QA is a preventative system involving all employees to ensure quality standards are met throughout development. In contrast, QC is reactive and conducted by a specialized team to detect defects in finished products before release. Both work together to continually meet customer requirements, with QA focusing on building quality in from the start and QC checking for quality along the way.
Qualification of laboratory equipments by Mayuri SoniMayuri Soni
The document provides standard operating procedures (SOPs) for qualifying common laboratory equipment used for quality control testing of pharmaceuticals. It describes calibration procedures for hardness testers, friability test apparatus, tap density apparatus, disintegration testers, and dissolution test apparatus. The SOPs outline how to test that the equipment meets specifications for factors like force measurements, rotation speeds, temperature control, and oscillations. Regular calibration is necessary to confirm equipment is functioning properly and producing accurate results.
The document discusses the qualification of analytical equipment like electronic balances and pH meters. It explains that qualification includes design, installation, operational and performance qualification to ensure equipment is properly installed and functioning accurately. Specific steps for qualifying balances, such as daily calibration checks with internal weights and yearly checks with external weights, are provided. The two-point calibration method for pH meters using buffer solutions is also described. Acceptance limits and record keeping procedures are outlined to ensure equipment remains calibrated over time.
This guidance provides recommendations for holders of animal drug applications on reporting categories for changes to conditions established in approved applications. It describes changes to manufacturing sites, scales, equipment, specifications, and processes for synthetic drug substances and intermediates. The guidance recommends reporting categories of annual reports, supplements for changes being effected in 30 days, or prior approval supplements based on the type and potential impact of changes.
In this slide contains details about Pharmaceutical validation of water system
Presented by: K VENKATSAI PRASAD (Department of pharmaceutical analysis and quality assurance).RIPER, anantapur
Sanitation in manufacturing premises is essential to prevent contamination of products. It requires keeping all areas clean, including the premises, manufacturing areas, equipment, and personnel. This involves removing dirt, waste, garbage and other sources of infection or disease. Cleaning and sanitation of premises and equipment helps ensure products are not contaminated during the manufacturing, processing, packing or holding of drug products.
This document discusses the qualification of manufacturing equipment. It explains that equipment qualification is necessary to ensure equipment works correctly and produces reliable results. There are four types of qualification: design, installation, operational, and performance. Design qualification defines equipment specifications. Installation qualification confirms proper installation. Operational qualification verifies equipment functions as specified. Performance qualification demonstrates consistent performance under routine use. The document then provides details on specific qualification procedures for dry powder mixers and fluidized bed dryers.
It is process of “Establishing documentary evidence that provide a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes”.
In the pharmaceutical industry, it is very important that in addition to final testing and compliance of products, it is also assured that the process will consistently produce the expected results.
Validation is action of proving in accordance with the principles of good manufacturing practices, that any procedure, process, equipment, material, activity or system actually leads to expected results.
Cleaning validation is documented evidence with a high degree assurance that one can consistently clean a system or a piece of equipment to predetermined and acceptable limits.
The primary regulatory concern driving the need for cleaning validation is cross contamination of the desired drug substance either by other API from previous batch runs or by residues from the cleaning agents used.
The prime purpose of validating a cleaning process is to ensure compliance with federal and other standard regulations
1. Cross contamination with active ingredients
Contamination of one batch of product with significant levels of residual active ingredients from previous batch cannot be tolerated.
In addition to the obvious problems posed by subjecting consumers or patients to unintended contaminants, potential clinically significant synergistic interactions between pharmacologically active chemicals are a real concern.
2. Contamination with unintended materials or compounds
While inert ingredients used in drug products are generally recognized as safe for human consumption, the routine use, maintenance and cleaning of equipment's provide the potential contamination with such items as equipment parts, lubricants and chemical cleaning agents3. Microbiological contamination
Maintenance , cleaning and storage conditions may provide adventitious microorganisms with the opportunity to proliferate within the processing equipment.
The document discusses validation of analytical methods used in cleaning validation. It covers parameters assessed in analytical method validation like specificity, linearity, range, accuracy, precision, LOD, LOQ. It also discusses method validation, cleaning validation, levels of cleaning, cleaning process validation, typical analytical procedures and their applicability. Key aspects of validation covered include equipment and personnel qualification, microbiological considerations, documentation, sampling, rinsing, rinse samples, detergents used and establishment of acceptable limits.
The document discusses validation of critical utility systems used in pharmaceutical manufacturing facilities. It focuses on validation of HVAC, water, and steam systems. For HVAC validation, it provides details on DQ, IQ, OQ, and PQ protocols including objectives, responsibilities, tests performed. It discusses user requirements, specifications for HVAC control and monitoring. For water system validation, it discusses purification methods, grade of water, and protocols for IQ, OQ and PQ. It also discusses two types of steam systems - house steam and clean steam - and validation considerations for each.
In this slide contains introduction, qualification, preventive maintenance, requalification method.
Presented by: Malarvannan M (Department of pharmaceutical analysis).RIPER, anantapur
PIC/S is a combine term used for the execution of activities of Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme
harmonize, educate, and update aspects relating to Good Manufacturing Practice among member countries
harmonized relation among regulatory authorities and governments
members
history
role
objective and function
guidlines
In this slide contains Investigation, reason, case study of OOS.
Presented by: K Venkatsai Preasad. (Department of pharmaceutical analysis and quality assurance).
RIPER, anantapur.
In this slide contains introduction, steps, requirements, principle and quantification methods of HPLC.
Presented by: HIMA BINDHU (Department of pharmaceutical analysis).
RIPER, anantapur
in this slide contains introduction, types, classification, review team, requirement of protocol and process of Investigated New Drug Application (IND).
Presented by: RAVI SHANKAR D (Department of pharmaceutical analysis and quality assurance),
RIPER, anantapur.
Preclinical Development, Introduction
Definition, Stages of development of a new drug, Objectives of Preclinical studies, Several steps in preclinical trials, Types of studies in Preclinical trials, Importance of preclinical trials
By
Ms. I. Sai Reddemma.
Department of Pharmacology
The document discusses in-process quality control (IPQC) in the pharmaceutical manufacturing process. It defines IPQC and introduces its importance in enforcing quality standards. The objectives of IPQC are outlined as optimizing processes, monitoring operations, and inspecting materials and equipment. Key aspects of IPQC addressed include sampling methods, in-process testing parameters, packaging controls, maintaining documentation, and releasing batches. The conclusion emphasizes that IPQC ensures product quality and conformity through monitoring critical stages of production.
In this slide contains introduction, principle, types, equipment's and applications of Enzyme linked immunosorbent assay.
Presented by: D.Sudheer Reddy. (Department of pharmacology)
RIPER, anantapur.
Target Validation
Introduction,Drug discovery, Target identification and validation, Target validation and techniques
By
Ms. B. Mary Vishali
Department of Pharmacology
This document outlines a seminar presentation on Quality by Design (QbD) in pharmaceutical development. It discusses key QbD concepts like the target product profile, critical quality attributes, risk assessment, design space, and control strategy. Tools used in QbD like design of experiments and process analytical technology are also summarized. The document provides an overview of the ICH Q8 guideline on pharmaceutical development and how QbD is viewed by regulators and the pharmaceutical industry.
The document presents information on Quality by Design (QbD), a systematic approach to pharmaceutical development that emphasizes product and process understanding. It defines key QbD concepts like target product profile, quality target product profile, critical quality attributes, critical material attributes, and critical process parameters. The benefits of QbD for industry include eliminating batch failures and empowering technical staff. Design space, design of experiments, and process analytical techniques are important tools in QbD. Regulatory agencies support the QbD approach for developing scientific understanding and continuous improvement.
In this slide contains plan, steps, tool involved in risk assessment.
Presented by: K VENKATSAI PRASAD (Department of pharmaceutical analysis and quality assurance).RIPER, anantapur
The document discusses quality by design (QbD) in pharmaceutical development. It defines QbD and describes its objectives to achieve quality products through a systematic approach involving predefined targets and process understanding. The key aspects of QbD include defining target product and quality profiles, identifying critical quality attributes and material/process parameters through risk assessment, establishing a design space, and implementing a control strategy with life cycle management. Various tools used in QbD such as design of experiments are also outlined.
In this slide contains the deep explanation of Methods of Determination for Drug-Excipient Compatibility Studies.
Presented by: G.Aravind Kumar (Department of industrial pharmacy),
RIPER, anantapur.
Introduction to Analytical Techniques in Phaese III,
Spectrophotometry, Reflectance photometry, Nephelometry & Turbidimetry, Osmometry, Potentiometry, Flowcytometry, Densitometry, Electrophoresis, LC-MS, ICP-MS
Presented by
B. Kranthi Kumar
Department of Pharmacology
In this slide contains analytical techniques in phase-3 clinical trials.
Presented by: KRANTHI KUMAR BONALA (Department of pharmacology).
RIPER, anantapur
UPLC refers to ultra performance liquid chromatography. It enhances speed, resolution, and sensitivity compared to HPLC by using particles less than 2μm in diameter. UPLC operates at very high pressures and provides better separation and faster analysis. It has applications in determining pesticides, analyzing pharmaceutical impurities, and more. UPLC offers advantages like reduced run time and solvent usage but also has disadvantages like higher back pressures reducing column life.
In this slide contains Calibration vs Qualification and phases of qualification.
Presented by: A.Siddartha Tharun Teja. (Department of industrial pharmacy).
RIPER, anantapur.
Similar to Analytical method validation as per USP (20)
The document describes the development of a new magnetic solid phase extraction (MSPE) adsorbent called polyDOPA@Ag-MNPs for the analysis of trace beta-blockers in biological samples. PolyDOPA@Ag-MNPs were synthesized by reducing silver ions on the surface of magnetic nanoparticles coated with poly(3,4-dihydroxyphenylalanine). The adsorbent was able to isolate beta-blockers from sample matrices using a magnetic field. Optimization of the MSPE method identified pH 7, 2 minutes adsorption time, 4 mg polyDOPA@Ag-MNPs, methanol containing 1% acetic acid as the eluent, 2 minutes elution
JOURNAL CLUB PRESENTATION (20L81S0402-PA & QA)
Presented by: K VENKATSAI PRASAD (Department of pharmaceutical analysis and quality assurance).RIPER, anantapur
In this slide contains Study of Quality of Raw Materials and General methods of analysis of Raw materials used in cosmetic manufacture as per BSI
Presented by: P.PAVAN KALYAN (Department of pharmaceutical analysis).RIPER, anantapur
In this slide contains Determination of Acid value, Saponification value and Ester value.
Presented by: P.NARESH (Department of pharmaceutical analysis).RIPER, anantapur
JAMES WEBB STUDY THE MASSIVE BLACK HOLE SEEDSSérgio Sacani
The pathway(s) to seeding the massive black holes (MBHs) that exist at the heart of galaxies in the present and distant Universe remains an unsolved problem. Here we categorise, describe and quantitatively discuss the formation pathways of both light and heavy seeds. We emphasise that the most recent computational models suggest that rather than a bimodal-like mass spectrum between light and heavy seeds with light at one end and heavy at the other that instead a continuum exists. Light seeds being more ubiquitous and the heavier seeds becoming less and less abundant due the rarer environmental conditions required for their formation. We therefore examine the different mechanisms that give rise to different seed mass spectrums. We show how and why the mechanisms that produce the heaviest seeds are also among the rarest events in the Universe and are hence extremely unlikely to be the seeds for the vast majority of the MBH population. We quantify, within the limits of the current large uncertainties in the seeding processes, the expected number densities of the seed mass spectrum. We argue that light seeds must be at least 103 to 105 times more numerous than heavy seeds to explain the MBH population as a whole. Based on our current understanding of the seed population this makes heavy seeds (Mseed > 103 M⊙) a significantly more likely pathway given that heavy seeds have an abundance pattern than is close to and likely in excess of 10−4 compared to light seeds. Finally, we examine the current state-of-the-art in numerical calculations and recent observations and plot a path forward for near-future advances in both domains.
Sexuality - Issues, Attitude and Behaviour - Applied Social Psychology - Psyc...PsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
This presentation offers a general idea of the structure of seed, seed production, management of seeds and its allied technologies. It also offers the concept of gene erosion and the practices used to control it. Nursery and gardening have been widely explored along with their importance in the related domain.
Mechanisms and Applications of Antiviral Neutralizing Antibodies - Creative B...Creative-Biolabs
Neutralizing antibodies, pivotal in immune defense, specifically bind and inhibit viral pathogens, thereby playing a crucial role in protecting against and mitigating infectious diseases. In this slide, we will introduce what antibodies and neutralizing antibodies are, the production and regulation of neutralizing antibodies, their mechanisms of action, classification and applications, as well as the challenges they face.
Discovery of An Apparent Red, High-Velocity Type Ia Supernova at 𝐳 = 2.9 wi...Sérgio Sacani
We present the JWST discovery of SN 2023adsy, a transient object located in a host galaxy JADES-GS
+
53.13485
−
27.82088
with a host spectroscopic redshift of
2.903
±
0.007
. The transient was identified in deep James Webb Space Telescope (JWST)/NIRCam imaging from the JWST Advanced Deep Extragalactic Survey (JADES) program. Photometric and spectroscopic followup with NIRCam and NIRSpec, respectively, confirm the redshift and yield UV-NIR light-curve, NIR color, and spectroscopic information all consistent with a Type Ia classification. Despite its classification as a likely SN Ia, SN 2023adsy is both fairly red (
�
(
�
−
�
)
∼
0.9
) despite a host galaxy with low-extinction and has a high Ca II velocity (
19
,
000
±
2
,
000
km/s) compared to the general population of SNe Ia. While these characteristics are consistent with some Ca-rich SNe Ia, particularly SN 2016hnk, SN 2023adsy is intrinsically brighter than the low-
�
Ca-rich population. Although such an object is too red for any low-
�
cosmological sample, we apply a fiducial standardization approach to SN 2023adsy and find that the SN 2023adsy luminosity distance measurement is in excellent agreement (
≲
1
�
) with
Λ
CDM. Therefore unlike low-
�
Ca-rich SNe Ia, SN 2023adsy is standardizable and gives no indication that SN Ia standardized luminosities change significantly with redshift. A larger sample of distant SNe Ia is required to determine if SN Ia population characteristics at high-
�
truly diverge from their low-
�
counterparts, and to confirm that standardized luminosities nevertheless remain constant with redshift.
Order : Trombidiformes (Acarina) Class : Arachnida
Mites normally feed on the undersurface of the leaves but the symptoms are more easily seen on the uppersurface.
Tetranychids produce blotching (Spots) on the leaf-surface.
Tarsonemids and Eriophyids produce distortion (twist), puckering (Folds) or stunting (Short) of leaves.
Eriophyids produce distinct galls or blisters (fluid-filled sac in the outer layer)
Embracing Deep Variability For Reproducibility and Replicability
Abstract: Reproducibility (aka determinism in some cases) constitutes a fundamental aspect in various fields of computer science, such as floating-point computations in numerical analysis and simulation, concurrency models in parallelism, reproducible builds for third parties integration and packaging, and containerization for execution environments. These concepts, while pervasive across diverse concerns, often exhibit intricate inter-dependencies, making it challenging to achieve a comprehensive understanding. In this short and vision paper we delve into the application of software engineering techniques, specifically variability management, to systematically identify and explicit points of variability that may give rise to reproducibility issues (eg language, libraries, compiler, virtual machine, OS, environment variables, etc). The primary objectives are: i) gaining insights into the variability layers and their possible interactions, ii) capturing and documenting configurations for the sake of reproducibility, and iii) exploring diverse configurations to replicate, and hence validate and ensure the robustness of results. By adopting these methodologies, we aim to address the complexities associated with reproducibility and replicability in modern software systems and environments, facilitating a more comprehensive and nuanced perspective on these critical aspects.
https://hal.science/hal-04582287
TOPIC OF DISCUSSION: CENTRIFUGATION SLIDESHARE.pptxshubhijain836
Centrifugation is a powerful technique used in laboratories to separate components of a heterogeneous mixture based on their density. This process utilizes centrifugal force to rapidly spin samples, causing denser particles to migrate outward more quickly than lighter ones. As a result, distinct layers form within the sample tube, allowing for easy isolation and purification of target substances.
Anti-Universe And Emergent Gravity and the Dark UniverseSérgio Sacani
Recent theoretical progress indicates that spacetime and gravity emerge together from the entanglement structure of an underlying microscopic theory. These ideas are best understood in Anti-de Sitter space, where they rely on the area law for entanglement entropy. The extension to de Sitter space requires taking into account the entropy and temperature associated with the cosmological horizon. Using insights from string theory, black hole physics and quantum information theory we argue that the positive dark energy leads to a thermal volume law contribution to the entropy that overtakes the area law precisely at the cosmological horizon. Due to the competition between area and volume law entanglement the microscopic de Sitter states do not thermalise at sub-Hubble scales: they exhibit memory effects in the form of an entropy displacement caused by matter. The emergent laws of gravity contain an additional ‘dark’ gravitational force describing the ‘elastic’ response due to the entropy displacement. We derive an estimate of the strength of this extra force in terms of the baryonic mass, Newton’s constant and the Hubble acceleration scale a0 = cH0, and provide evidence for the fact that this additional ‘dark gravity force’ explains the observed phenomena in galaxies and clusters currently attributed to dark matter.
1. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
ANALYTICAL METHOD
VALIDATION AS PER USP
1
Presented by
P. Sudheer Kumar
(20L81S0714)
Department of Pharmaceutical
Analysis
2. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
Contents
• Introduction
• Objective
• Types of analytical procedures to be validated
• Validation parameters as per USP
• Conclusion
• References
2
3. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
Introduction
• Validation is the documented act of proving that any procedure,
process, equipment, material, activity or system actually leads to
the expected result.
• Analytical method validation is a process of documenting/proving
that an analytical method provides analytical data acceptable for
the intended use.
• A pharmaceutical drug product must meet all its specifications
through out its shelf-life.
3
4. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
• The method of analysis used must be validated. This is required to
ensure the product’s safety and efficacy through out all phases of
its shelf-life
Objective:
• The main objective of analytical validation is to ensure that a
selected analytical procedure will give reproducible and reliable
results that are adequate for the intended purpose.
• This is applicable to all the procedures either pharmacopoeial and
nonpharmacopoeial.
4
Cont…
5. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
*The required validation parameters also termed “ analytical
performance characteristics”, depends upon the type of analytical
method. Pharmaceutical analytical methods are characterized into 5
types.
Identification tests
Potency assays
Limit tests for the control of impurities
Impurity tests- quantitative
Specific tests
5
Types of analytical procedures to be
validated
6. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
1. Specificity
2. Linearity
3. Range
4. Accuracy
5. Precision
6. Limit of detection
7. Limit of quantitation
8. Robustness
9. SST
6
Validation parameters as per USP
7. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
1. Specificity :
Specificity is the ability to assess unequivocally the analyte in
presence of components which may be expected to be present.
Determination :
• Identification tests
• Assay and impurity test(s)
Impurities are available
Impurities are not available
7
8. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
2. Linearity:
• The Ability of the method to obtain test results that are directly
proportional to concentration within a given range. Method:
dilution of stock solution/separate weightings
• Minimum 5 concentrations are used.
8
9. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
3.Range Definition:
The interval between the upper and lower concentrations of analyte
in the sample that have been demonstrate to have a suitable level of
precision, accuracy, and linearity.
• Established by confirming that the method provides acceptable
degree of linearity, accuracy, and precision.
• Specific range dependent upon intended application of the
procedure.
9
10. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
Cont…
• Assay: 80 to 120% of test concentration.
• Content uniformity: 70 to 130% of test concentration.
• Dissolution: 20% to 120%
• Impurities reporting level: 120% of specification limit (with
respect to test concentration of API)
10
11. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
4. Accuracy Definition:
The accuracy of an analytical procedure is the closeness of agreement
between the values that are accepted either as conventional true
values or an accepted reference value and the value found.
Determination of
Assay
i. Drug substance
ii. Drug product
Impurities (quantitation)
11
12. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
• Recommended data: Assessed by 9 determinations over a
minimum of 3 concentration levels covering a specified range.
• Limit:
i. Typical accuracy of the recovery of the drug substance is
expected to be about 99 – 101%.
ii. Typical accuracy of the recovery of the drug product is expected
to be about 98 – 102%.
12
Cont…
13. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
5. Precision Definition:
The closeness of agreement (degree of scatter) between a series of
measurements obtained from multiple samplings of the same
homogeneous sample.
• Precision includes:
i. Repeatability
ii. Intermediate Precision
iii. Reproducibility
13
14. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
i. Repeatability:
• Repeatability expresses the precision under the same operating
conditions over a short interval of time.
• Repeatability should be assessed using a minimum of 9
determinations covering the specified range.
ii. Intermediate precision
• Intermediate precision expresses variations within laboratories,
such as different days, different analysts, different equipment etc.
14
15. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 15
iii. Reproducibility:
Reproducibility expresses the precision between laboratories.
16. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
6. Limit of detection:
It is the lowest amount of analyte in a sample which can be detected
but not necessarily quantitated.
7. Limit of quantitation:
It is the lowest amount of analyte in a sample which can be
quantitatively determined with suitable precision and accuracy.
16
17. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
Determination of LOD and LOQ
Limit of detection:
• Based on visual examination.
• Based on standard deviation of response and slope.
• Signal to noise ratio 2:1 or 3:1
Limit of quantitation:
• Based on visual examination.
• Based on standard deviation of response and slope.
• Signal to noise ratio 10:1
17
18. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
8. Ruggedness Definition:
The ruggedness of an analytical method is the degree of
reproducibility of test results obtained by the analysis of the same
samples under a variety of conditions, such as different laboratories,
different analysts, different instruments, different days, etc.
i Certain may include
i. Source
ii. Concentration and stability of solution
iii. Heating rate
iv. Column temperature
v. Humidity
18
19. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
Robustness Definition:
“The robustness of an analytical procedure is a measure of its
capacity to remain unaffected by small, but deliberate variations in
method parameters and provides an indication of its reliability
during normal usage”. Determination: The evaluation of robustness
should be considered during the development phase and depends
on the type of procedure under study.
19
20. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
Cont…
Variations may include:
• stability of analytical solution
• variation of pH in a mobile phase
• different column (lot/supplier)
• temperature
• flow rate
20
21. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
9. System suitability
• System suitability testing is an integral part of many analytical
procedures.
• The tests are based on the concept that the equipment,
electronics, analytical operations and samples to be analyzed
constitute an integral system that can be evaluated as such.
• System suitability testing has been recommended by USP in
HPLC procedures.
21
22. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
Conclusion
• When the method is properly validated consistent, reliable and
accurate results are obtained.
• Analytical method validation is an important analytical tool to
ensure the accuracy and specificity of the analytical procedures
with a precise agreement.
• Validation of analytical methods is also required by regulations.
• Hence it is very important to validate any analytical method that
has been developed.
22
23. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
References
1. Gupta P. C method validation of analytical procedures. pharmatutor..
2. Lopez P, Buffoni E, Pereira F, Vilchez Quero J. Analytical Method Validation.
Wide Spectra of Quality Control.
3. [Internet]. Who.int. 2016 [cited 2 March 2019].
4. https://www.who.int/medicines/areas/quality_safety/quality_assurance/Gu
ideline_Validation _AnalyticalMethodValidationQAS16-671.pdf
5. Daksh S. VALIDATION OF ANALYTICAL METHODS – STRATEGIES &
SINGFICANCE. International Journal of Research and Development in
Pharmacy and Life Sciences.
6. [Internet]. Ich.org. [cited 2 March 2019].
https://www.ich.org/fileadmin/PublicWebSite/ICH_Products/Guidelines/Qu
ality/Q2 _R1/Step4/Q2_R1Guideline.pdf
7. Sharma P. validation in pharmaceutical industry. 2nd ed. Delhi: Vandana
publications.
23
24. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 24